"Cross-Reactivity of Neutralizing Antibodies Against SARS-CoV-2 in Patients Infected by Various Clades (S, L, V, GR, G, GH and GV)"

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsive for the most recent worldwide pandemic since December 2019. The present study aimed to determine the characteristics of neutralizing antibody cross-reactions of coronavirus disease 2019 (COVID-19)-causing variant viruses compared with those of non-variant viruses. Seven virus clades (S, L, V, GR, G, GH, and GV) were isolated and confirmed in the sera of 19 patients diagnosed with COVID-19.